Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition Amazon

Validation of the Arm-Type Fully Automatic Blood Pressure Monitor DBP-62F4B-P in adolescents and adults according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (ISO 81060-2:2018+Amd 2:2024) standard.

Xiaojin Guo
Aug 2026 · Blood Pressure Monitoring · 0 citations · 14 references
Medicine

TL;DR

The Arm-Type Fully Automatic Blood Pressure Monitor (model: DBP-62F4B-P) meets the accuracy and consistency requirements of the AAMI/ESH/ISO standard for SBP and DBP measurement in adolescents and adults with arm circumference 22.0-42.0 cm and is suitable for home use based on its design features and validation performance.

Abstract

Objective

To validate the accuracy and safety of the Arm-Type Fully Automatic Blood Pressure Monitor (model: DBP-62F4B-P) manufactured by JOYTECH Healthcare Co., Ltd. for blood pressure (BP) measurement in adolescents and adults with arm circumference 22.0-42.0 cm, in accordance with the Association for the Advancement of Medical Instrumentation (AAMI)/European Society of Hypertension (ESH)/International Organization for Standardization (ISO) (ISO 81060-2:2018+Amd 2:2024) international standard.

Methods

A total of 90 subjects were enrolled. Three valid datasets were collected from each subject, yielding 270 datasets for analysis. The mercury sphygmomanometer (reference device) data were used as the gold standard to evaluate whether the accuracy of the test device met the requirements.

Results

Based on 270 valid datasets, the mean difference between the test device and the reference device for SBP was -0.49 mmHg (SD = 7.29 mmHg), and for DBP was 1.45 mmHg (SD = 6.14 mmHg), meeting Criterion 1 requirements. Analysis based on individual averages of the 90 subjects showed a mean difference of -0.49 mmHg (SD = 5.57 mmHg) for SBP and 1.45 mmHg (SD = 5.05 mmHg) for DBP, both meeting the requirements of Criterion 2. The device maintained stable measurement performance across different arm circumferences, ages, and BP levels.

Conclusion

The Arm-Type Fully Automatic Blood Pressure Monitor (model: DBP-62F4B-P) meets the accuracy and consistency requirements of the AAMI/ESH/ISO (ISO 81060-2:2018+Amd 2:2024) standard for SBP and DBP measurement in adolescents and adults with arm circumference 22.0-42.0 cm. It can be safely and effectively used for BP monitoring in clinical settings and, by extension, is suitable for home use based on its design features and validation performance.

DOI PubMed Semantic Scholar
View source

Similar papers

Aug 2026

Clinical investigation of the iHealth Track KN-550BT upper-arm blood pressure monitor in pregnant patients according to the ISO 81060-2:2018+AMD1:2020/AMD2:2024.

The iHealth Track KN-550BT upper-arm oscillometric upper-arm automated BP monitor fully complies with the requirements of ISO 81060-2:2018+AMD1:2020/AMD2:2024, and can be recommended for clinical application and home self-BP measurement among pregnant patients.

Ying Zhang, Dongmei Wang, Chunmei Cui et al. · 0 citations
#software testing Open access Aug 2026

Evaluation of Alysis-001 cuffless blood pressure estimation algorithm against the European Society of Hypertension awake/asleep test criteria in hypertensive patients.

This represents the first evaluation of a Device Type 3 cuffless blood pressure algorithm (automated, wearable, demographic-calibrated, not at heart level) meeting ESH awake/asleep test criteria, suggesting Alysis-001's potential as a clinically viable alternative for ambulatory blood pressure monitoring in hypertensive patients.

Kazuhiro Hongyo, Atsushi Hirayama, Kosuke Shimizu et al. · 0 citations
Open access Jul 2026

Continuous BP monitoring of ICU Taiwanese patients: training-phase evaluation of oCare™ BP100 according to ISO 81060-3: 2022

It is demonstrated that a training-phase evaluation of Type T mode continuous automated non-invasive sphygmomanometer repeated SBP, DBP, and MAP measurement of oCare™ BP100 in Type T mode are stable across various analysis periods and patients.

Chao-Lun Lai, Yeh-Wen Lee, Chia-Fang Chang et al. · 0 citations
Open access Aug 2026

Assessing the reliability and validity for metabolic syndrome diagnosis using point-of-care analyzers in a mobile setup - a pilot study

The metabolic syndrome (MetS) is characterized by having three or more of these risk factors: increased blood glucose (Glc), serum triglycerides (TG), blood pressure (BP), waist circumference (WC), and reduced high-density lipoprotein (HDL). Mobile diagnostics using point-of-care (POC) blood analyzers could help identify individuals at risk. This pilot study assessed reliability and validity of MetS risk factor analysis using POC analyzers in a mobile examination unit. Fifty participants (52 ± 7y; 170 ± 10 cm; 80 ± 19 kg, m/f: 21/29) were included for analysis. The mobile examination unit was equipped with different POC analyzers (Alere, LABGEO, CardioChek for Glc, HDL, TG; Quo-Test-A1C Testkit for HbA1c‘). Agreement compared to a reference laboratory (RefLab) was analyzed by Bland-Altman (bias, Limits of Agreement (LoA)), ICC, SEM and McNemar’s test. Test-retest analysis was assessed on two different days (max. two weeks apart) using Spearman’s rho, ICC, test-retest variability (TRV%) and McNemar’s test. Based on the smallest bias and low number of missing values (Glc: -5 [LoA − 25 to 6] mg/dl; TG: 8 [LoA − 58 to 30] mg/dl; HDL: -2 [LoA − 14 to 9] mg/dl), and the highest agreement in MetS diagnosis compared to the results of RefLab, the Alere POC device was chosen. Test-retest reliability (n = 16) for MetS risk factors and HbA1c measured in the mobile setup ranged from poor to excellent with low TRV (0.9–5.8%). Risk factor classification and MetS diagnosis did not differ between measurement days. A mobile setup using the Alere POC analyzer could be used as a valid mobile screening method for MetS to ensure early detection of risk factors.

S. Houtenbos, A. Schraplau, P. Wippert et al. · 0 citations
Review Open access Aug 2026

Wearable, cuffless, and portable devices for blood pressure monitoring (2015–2025): a scoping review of technologies, calibration, clinical validation, and regulatory frameworks

The 2015–2025 ecosystem shows rapid progress and a transition toward cuffless-specific validation, however, clinical utility depends on intended use, population, calibration/recalibration, and setting, and performance should not be extrapolated across technologies, populations, or contexts.

J. C. Bustamante-Rodríguez, Jhosmer Ballena-Caicedo, Julio César Bautista-Zuta et al. · 0 citations
Jul 2026

Validation of the Microlife WatchBP O3 (BP3SZ1-1) upper-arm, oscillometric blood pressure device in pregnancy according to ISO 81060-2:2018.

To assess the accuracy of the Microlife WatchBP O3 upper-arm, oscillometric blood pressure (BP) device, suitable for clinic, home, and ambulatory use, in a pregnant population. This device was assessed according to the ISO 81060-2:2018 protocol in 45 pregnant women, including women with gestational hypertension and pre-eclampsia. Two cuff sizes were available for arm circumferences of 22-32 and 32-42 cm. Nine sequential same-arm measurements were obtained from each participant, alternating between the test device and auscultation. Forty-nine women were included, and four were excluded. Data from 45 women, including 14 women with gestational hypertension and 15 women with pre-eclampsia, were analyzed according to the protocol. The mean difference with SDs were 0.6 ± 7.9 mmHg for SBP and 3.4 ± 6.0 mmHg for DBP. The Microlife WatchBP O3 upper-arm, oscillometric BP device passed the criteria of the ISO 81060-2:2018 standard in normotensive pregnant women, women with gestational hypertension, and women with pre-eclampsia.

A. de Greeff, Catherine A Cluver, A. Shennan · 0 citations